APONTIS PHARMA AG had a revenue of 26.03M in the quarter ending Jun 30, 2025, with 1.13%. This bring the company's revenue in the last twelve months to 51.77M, Decreased 6.82%. In the fiscal year ending Dec 31, 2024, APONTIS PHARMA AG had annual revenue of 48.47M with 31.12% growth.